Genome-editing medicinal products: the EMA perspective

Nat Rev Drug Discov. 2024 Apr;23(4):242-243. doi: 10.1038/d41573-024-00050-2.
No abstract available

Publication types

  • News

MeSH terms

  • CRISPR-Cas Systems
  • Gene Editing*
  • Genome*
  • Humans